As of June 30, 2026, BioHarvest Sciences Inc. has 22.67M shares outstanding.
| Shares Outstanding | 22.67M |
These figures are as of June 30, 2026. The price-to-sales ratio is 1.69, and the price-to-book ratio stands at 3.28.
| PS Ratio | 1.69 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | -9.54 |
| P/OCF Ratio | -7.03 |
These figures are as of June 30, 2026. The EV/Sales ratio of 1.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.
| EV / Sales | 1.81 |
As of June 30, 2026, BioHarvest Sciences Inc. maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.41, indicating elevated leverage, while an interest coverage ratio of -2.27 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.24 |
| Quick Ratio | 1.75 |
| Debt / Equity | 79.41 |
| Debt / EBITDA | -3.38 |
| Interest Coverage | -2.27 |
Over the twelve months ended June 30, 2026, BioHarvest Sciences Inc. posted a negative return on equity (ROE) of -283.38, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -30.60, reflecting losses generated across the asset base. Inventory turnover of 2.94 indicates how many times BioHarvest Sciences Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -283.38 |
| Return on Assets (ROA) | -30.60 |
| Inventory Turnover | 2.94 |
As of the close on November 16, 2026, BioHarvest Sciences Inc.'s stock has declined approximately 80.91% over the past 52 weeks. The 50-day moving average sits at 1.63, while the 200-day moving average is 3.05.
| 52-Week Price Change | -80.91% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 3.05 |
Over the twelve months ended June 30, 2026, BioHarvest Sciences Inc. posted a gross margin of 58.95, reflecting its pricing power and cost economics. The operating margin of -17.99 and net profit margin of -31.21 provide insight into operational efficiency.
| Gross Margin | 58.95 |
| Operating Margin | -17.99 |
| Pretax Margin | -30.94 |
| Profit Margin | -31.21 |
| EBITDA Margin | -13.09 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -10.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.73, meaning BioHarvest Sciences Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -35.73 |
| FCF Yield | -10.48 |
BioHarvest Sciences Inc.'s most recent stock split took place on June 3, 2024 with a 35:1 split ratio.
| Last Split Date | 6/3/2024 |
| Split Ratio | 35:1 |
As of June 30, 2026, BioHarvest Sciences Inc. has an Altman Z-Score of -1.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.30 |
Already premium?